Posts from ‘February, 2009’

Strategic acquisition will significantly expand AMICAS’ presence in image and information management market BOSTON, and BIRMINGHAM, Ala., Feb. 23 (HSMN NewsFeed) — AMICAS, Inc. (Nasdaq: AMCS ), a leader in radiology and clinical image and information …
Devices, Radiology, Mergers & Acquisitions
AMICAS, Emageon

Spinal Stenosis is the Most Frequent Spinal Disorder Diagnosis for Individuals 65 Years and Older CARLSBAD, Calif., Feb. 23, 2009 –(HSMN NewsFeed) — Alphatec Holdings, Inc. (NasdaqGM:ATEC ), the parent company of Alphatec Spine, Inc., a pharmaceutical device…
Devices, Neurosurgery, Orthopaedic, Licensing
Alphatec Holdings, Helix Point, Helifix, Helifuse, interspinous device

IRVINE, Calif., Feb. Twenty (HSMN NewsFeed) -. Alsius Corporation (Nasdaq: ALUS ) announced today that it has signed an agreement with a wholly- owned subsidiary of ZOLL Medical Corporation (Nasdaq: ZOLL ) under which Alsius will sell to ZOLL substantially a…
Devices, Acquisitions
Alsius, ZOLL Laboratory, intravascular temperature management

ABBOTT PARK, Ill., Feb. 20 (HSMN NewsFeed) — Abbott (NYSE: ABT) today announced that it has received merger control clearance from the European Commission for its acquisition of Advanced Medical Optics (AMO) through a cash delicate offer for the outstandi…
Devices, Ophthalmology, Mergers & Acquisitions
Abbott, Advanced Pharmaceutical Optics

FARMINGDALE, N.Y., Feb. 20 (HSMN NewsFeed) — Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic pharma device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has e…
Devices, Distribution
Misonix, LAVI Industrial & Clinical Agencies, SonaStar, BoneScalpel

Encouraging Safety and Efficacy Results Support Follow-on NEST-3 Trial CARLSBAD, California, February 20 (HSMN NewsFeed) — In a clinical trial sponsored by PhotoThera, Inc., transcranial laser therapy (TLT) for acute ischemic stroke within 24 hours o…
Devices, Neurology
PhotoThera, transcranial laser therapy, stroke, NEST-2, NEST-3

Shire to acquire product rights and staff for Equasym(R) IR and Equasym(R) XL UCB to receive up-front payment of EUR 55 million UCB continues to focus on its core areas, as outlined in the SHAPE programme BRUSSELS, BELGIUM–UCB has agreed the sa…
Biopharmaceuticals, Acquisitions
UCB, Shire plc, Equasym, methylphenidate, ADHD

LEXINGTON, Ky., Feb. Twenty (HSMN NewsFeed) — Bariatric surgeons at Central Baptist Hospital made U.S. medical history Feb. 16 by performing a groundbreaking bariatric procedure to slash the capacity of a patient’s stomach without making a single incisio…
Devices, Surgery
USGI Clinical, EndoSurgical Operating System, bariatric surgery, endoscopic

Soh Fujiwara is Appointed Managing Director TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 (HSMN NewsFeed) — Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that it has officially opened a…
Biopharmaceuticals, Personnel
Shire Plc

PHILADELPHIA and DUBLIN, February 20 (HSMN NewsFeed) — Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has signed an agreement with UCB to acquire the worldwide rights to EQUASYM® IR and XL (met…
Biopharmaceuticals, Acquisitions
Shire Plc, UCB, EQUASYM IR, EQUASYM XL, methylphenidate, ADHD